Lingyan Zhu1*
Zhanguo Su- 1School of Humanities, Gannan Health Vocational College, Ganzhou, Jiangxi, China
- 2Faculty of Sports and Exercise Science, University of Malaya, Kuala Lumpur, Malaysia
- 3Faculty of Physical Education, Yunnan Nationalities University, Kunming, Yunnan, China
Sarcopenia, the progressive and generalized loss of skeletal muscle mass, strength, and function with aging, poses a significant public health challenge. A key contributor to sarcopenia is the accumulation of DNA damage, both nuclear and mitochondrial, coupled with a decline in DNA repair efficiency. This genomic instability, exacerbated by chronic oxidative stress and inflammation, impairs critical cellular processes including protein synthesis, mitochondrial function, and satellite cell regenerative capacity, ultimately leading to myofiber atrophy and weakness. Intriguingly, regular physical exercise, while acutely inducing transient DNA damage, concurrently activates and enhances DNA damage repair pathways, serving as a powerful physiological modulator of genomic integrity. This review comprehensively explores the intricate interplay between exercise, DNA damage, and DNA repair in the context of age-related muscle decline. We delve into the molecular hallmarks of DNA damage (e.g., 8-OHdG, SSBs, DSBs) and the major repair mechanisms (BER, NER, MMR, HR, NHEJ), detailing how acute exercise modalities (e.g., high-intensity interval training, resistance training) induce specific damage types primarily via reactive oxygen species. Crucially, we synthesize emerging evidence suggesting that chronic exercise training may upregulate the efficiency and capacity of DNA repair enzymes, particularly OGG1 in base excision repair, thereby mitigating the accumulation of deleterious genomic lesions. This exercise-induced enhancement of DNA repair directly contributes to maintaining mitochondrial health, preserving muscle stem cell function, and combating cellular senescence and inflammation, ultimately delaying or ameliorating sarcopenia and improving muscle functional outcomes in older adults. We highlight critical gaps in understanding the precise modulation of all repair pathways by exercise and propose future research directions, including advanced biomarker development and personalized exercise prescriptions, to harness the therapeutic potential of DNA repair for healthy muscle aging.
1 Introduction
Sarcopenia, characterized by the progressive decline in skeletal muscle mass and strength, represents a formidable public health challenge in the context of an aging global population (Colleluori and Villareal, 2021). This condition is increasingly recognized not merely as an unavoidable consequence of chronological aging but as a distinct disease, as evidenced by its inclusion in the International Classification of Disease, 10th Revision, Clinical Modification (ICD-10-CM) (Goodfield and Tsurumi, 2024). The implications of sarcopenia are profound, extending to increased physical frailty, heightened disability, and an elevated risk of falls and mortality among older adults (Lee et al., 2021; Xu et al., 2022; Wang H. et al., 2021; Purnamasari et al., 2022).
The prevalence of sarcopenia underscores its widespread impact. Estimates vary depending on diagnostic criteria and geographical region, but figures range from approximately 11%–20% in Europe (Lee et al., 2024). Crucially, the prevalence escalates dramatically with advancing age, rising from about 1.5% in individuals aged 60–69 years to a striking 33.1% or more in those 80 years and older (Gao et al., 2025; Rafiyan et al., 2025). This escalating prevalence, driven by the global increase in life expectancy, translates directly into a significant burden on healthcare systems and national economies. The diminished physical function, increased frailty, and loss of independent living associated with sarcopenia lead to substantial medical costs and long-term care needs (Xu et al., 2022; Gao et al., 2025; Almohaisen et al., 2022). Consequently, research into effective prevention and management strategies for sarcopenia is not merely a biological imperative but a critical societal and economic challenge, highlighting the urgent need for comprehensive scientific understanding and intervention. At the molecular level, a foundational driver of the aging process is the progressive loss of genomic integrity (López-Otín et al., 2013). The integrity of the genome is fundamentally important for the survival and proper function of cells, tissues, and the entire organism (Bilal et al., 2024). DNA is under incessant assault from a multitude of factors. Endogenous sources of damage, arising from normal cellular processes, include errors during DNA replication, spontaneous base deamination, and the generation of reactive oxygen species (ROS) as byproducts of metabolism (Alghoul et al., 2023; Schumacher et al., 2021). Exogenous agents, such as ultraviolet (UV) radiation, ionizing radiation, and various environmental toxins and chemical mutagens, also inflict damage upon the genetic material (Bilal et al., 2024). The accumulation of such unrepaired DNA damage and the resultant genomic instability are recognized as a foundational hallmark of the aging process itself (López-Otín et al., 2013).
The unique susceptibility of skeletal muscle to DNA damage stems from its inherent characteristics. As a highly metabolically active tissue, muscle generates substantial amounts of ROS (Bou Saada et al., 2017). Furthermore, mature muscle fibers are largely post-mitotic, meaning they do not undergo frequent cell division (Gensler and Bernstein, 1981). In rapidly dividing cells, many DNA lesions are incompatible with replication and must be repaired to prevent cell cycle arrest or cell death (Lagunas-Rangel, 2023; Zhao et al., 2023a). Post-mitotic cells like mature muscle fibers, however, lack this immediate replicative pressure. Consequently, while they may avoid division-linked cell death, unrepaired DNA damage is not as critically required to be cleared and is instead permitted to persist and accumulate over the lifespan. This accumulation of both unrepaired lesions and new mutations arising from misrepair constitutes a state of progressive genomic instability (Schumacher et al., 2021). These accumulated lesions and mutations can directly impair essential DNA metabolic processes, most notably by stalling transcription (RNA synthesis), which subsequently disrupts protein synthesis and other functions critical for maintaining muscle homeostasis. This persistent, accumulating damage can directly impair gene expression and protein synthesis, processes critical for maintaining muscle function (Pezone et al., 2023; Bordin et al., 2021). This makes genomic instability a particularly impactful hallmark of aging in skeletal muscle, suggesting that interventions aimed at preserving genomic stability in this specific tissue could yield substantial functional benefits.
Physical exercise is widely acknowledged as a powerful intervention for promoting health, inducing profound adaptive responses in skeletal muscle, and offering robust protection against age-related decline and numerous chronic diseases (Rebelo-Marques et al., 2018). However, the relationship between exercise and cellular homeostasis, particularly genomic integrity, is complex and presents a fascinating paradox. While regular physical activity is undeniably beneficial, acute bouts of exercise, especially if unaccustomed or performed at exhaustive intensities, can transiently increase the production of reactive oxygen species (ROS) and consequently induce DNA damage within skeletal muscle (He et al., 2016).
This concept posits that low-to-moderate levels of stress, including transient DNA damage, act as crucial signaling molecules that activate beneficial adaptive responses within the cell. These adaptive responses encompass the enhancement of DNA repair mechanisms and the strengthening of endogenous antioxidant defense systems (Cobley et al., 2015). Conversely, excessive or chronic unmitigated stress can overwhelm cellular defenses and become detrimental.
Despite the recognized importance of both genomic integrity and physical exercise in the context of aging, the precise molecular mechanisms by which exercise-induced DNA damage and subsequent repair pathways influence age-related muscle weakness and sarcopenia remain an area of intense and active investigation. This comprehensive review aims to synthesize the current state of knowledge, critically evaluate existing evidence, and propose a robust framework for understanding the intricate interplay between exercise, DNA damage, DNA repair, and the pathogenesis and mitigation of sarcopenia. A central focus will be placed on analyzing the dual impact of acute and chronic exercise on genomic stability in muscle, elucidating how exercise can both transiently induce damage and, more importantly, orchestrate the upregulation of sophisticated DNA repair machinery. Furthermore, the molecular signaling pathways that mediate exercise-induced DNA repair and muscle adaptation will be meticulously examined. Ultimately, this review will highlight how exercise-enhanced DNA repair serves as a crucial therapeutic avenue for mitigating sarcopenia, identifying critical knowledge gaps, and charting promising future research directions to advance the field towards more effective interventions for healthy muscle aging.
2 DNA damage and repair in skeletal muscle: a foundation for understanding age-related decline
2.1 Endogenous and exogenous sources of DNA damage in muscle
Skeletal muscle, a highly dynamic and metabolically active tissue, is continuously exposed to diverse forms of DNA damage originating from both endogenous and exogenous sources (Bou Saada et al., 2017). Endogenous damage is a pervasive threat, arising from the inherent chemical instability of genetic material under physiological conditions (Bilal et al., 2024). Key internal culprits include errors that occur during cellular replication, spontaneous deamination of DNA bases, and, most significantly, the generation of ROS (Zhao et al., 2023b; Welch and Tsai, 2022; Shadfar et al., 2023). ROS are produced as a consequence of normal cellular metabolism, particularly during muscle contraction, where high oxygen consumption leads to the partial reduction of oxygen to superoxide radicals within mitochondria. Other endogenous sources of ROS in muscle include hypoxia, inflammation, and processes related to muscle regeneration (de Almeida et al., 2022; Rafiyan et al., 2023). Exogenous DNA damage, on the other hand, is primarily inflicted by environmental factors such as ionizing and UV radiations, as well as various chemical agents like aromatic amines, alkylating agents, and other toxins (Liu et al., 2024).
The high prevalence of oxidative DNA damage, especially 8-OHdG, in skeletal muscle is a direct consequence of its high metabolic activity and substantial oxygen consumption (Naimo et al., 2024; Wang F. et al., 2021). This chronic accumulation of oxidative DNA damage directly contributes to cellular dysfunction, impaired gene transcription, and reduced protein synthesis in muscle (Lu et al., 2023; Yousefzadeh et al., 2021). This fundamental molecular process provides a clear explanation for the age-related decline in muscle strength and stamina, which is a defining characteristic of sarcopenia. Table 1 provides an overview about major types of DNA damage and their corresponding repair pathways in skeletal muscle.
Table 1. Major types of DNA damage and their corresponding repair pathways in skeletal muscle.
2.2 Age-associated Impairments in DNA repair capacity and accumulation of genomic lesions
A hallmark of biological aging is the progressive decline in the capacity of cells to repair DNA damage (Zhao et al., 2023a; Yousefzadeh et al., 2021). This age-associated reduction in repair efficiency, coupled with continuous exposure to both endogenous and exogenous genotoxic agents, inevitably leads to a progressive accumulation of unrepaired DNA damage within tissues and organs, including skeletal muscle (Bou Saada et al., 2017). This accumulation of genomic lesions is considered a key causal factor in the overall aging process (Maynard et al., 2015).
Mitochondrial DNA (mtDNA) is particularly vulnerable to age-related genomic instability. The persistence of unrepaired mtDNA lesions (damage), coupled with misrepair events, leads to the significant accumulation of mutations (such as deletions and point mutations) in aged muscle tissue (Chatterjee and Walker, 2017). This accumulation of both persistent lesions and mutations in mtDNA correlates strongly with impaired mitochondrial function and is a direct contributor to the pathogenesis of sarcopenia (Melov et al., 1995; Pinto and Moraes, 2015). Beyond direct DNA sequence modification, defects in telomere maintenance, which is a specialized form of targeted DNA repair crucial for genome stability, are also closely associated with cellular senescence and the aging phenotype (Gao and Pickett, 2022; Selvi et al., 2025). Studies have demonstrated that an increased DNA repair capacity is positively correlated with greater longevity. This age-related decline in DNA repair efficiency means that the constant burden of genotoxic stress is no longer effectively managed, resulting in a progressive accumulation of unrepaired lesions and mutations from misrepair (Maynard et al., 2015). This accumulating genomic instability then directly contributes to the induction of cellular senescence and the exhaustion of stem cell populations (López-Otín et al., 2013). The exhaustion of regenerative capacity, particularly concerning muscle satellite cells (MuSCs), is a direct and profound contributor to sarcopenia (Careccia et al., 2023; Sousa-Victor et al., 2022; Huo et al., 2022). This represents a critical ripple effect where fundamental genomic instability directly impacts the tissue’s ability to maintain and repair itself throughout the lifespan. Thus, preserving genomic integrity is not solely about preventing mutations, but about sustaining the very capacity for tissue self-renewal, which is essential for healthy muscle aging (Figure 1).
Figure 1. Mechanisms Linking DNA Damage to Sarcopenia. This schematic illustrates the etiology and downstream consequences of genomic instability during muscle aging. (2.1) Sources of DNA Damage. Both endogenous sources (cellular metabolism/ROS, replication errors, inflammation) and exogenous sources (UV and ionizing radiation, chemical agents/toxins) contribute to the accumulation of DNA lesions, such as 8-OHdG and mutations, within the myonucleus. This nuclear damage results in impaired transcription and reduced protein synthesis, ultimately causing muscle weakness. (2.2) Age-Associated Impairments and Consequences. In contrast to young muscle, which possesses efficient DNA repair capacity, aged muscle exhibits a declining capacity for repair, leading to a progressive accumulation of unrepaired lesions and mutations. This genomic instability drives three key impairments: mitochondrial dysfunction (mtDNA mutations), telomere shortening coupled with cellular senescence, and stem cell exhaustion (MuSCs depletion), all of which converge to cause sarcopenia, characterized by the loss of muscle mass and function (Image was drawn by Adobe illustrator).
3 The multifaceted pathogenesis of sarcopenia: a molecular perspective
3.1 Key molecular and cellular hallmarks contributing to sarcopenia
Sarcopenia is driven by a complex interplay of aging mechanisms. The primary molecular and cellular hallmarks contributing to this decline include:
Genomic instability: The accumulation of DNA damage serves as a primary upstream driver.
Telomere attrition: The shortening of chromosomal ends leading to replicative senescence.
Epigenetic alterations: Changes in methylation and histone modification patterns.
Loss of proteostasis and deregulated nutrient-sensing: A concerted failure in protein quality control and metabolic signaling (grouped to reflect their functional synergy).
Mitochondrial dysfunction: Bioenergetic failure and oxidative stress.
Satellite cell exhaustion: The depletion of the regenerative pool.
Cellular senescence: The accumulation of arrested, pro-inflammatory cells.
Altered intercellular communication: Encompassing chronic inflammation (inflammaging) and neuromuscular junction degeneration.
A critical observation is that many of these seemingly distinct hallmarks are not isolated but are profoundly interconnected, forming an intricate pathological network where DNA damage and its repair often serve as central nodes or exacerbating factors (Riuzzi et al., 2018). For instance, mitochondrial dysfunction leads to increased reactive oxygen species (ROS) production and mitochondrial DNA (mtDNA) damage, which in turn fuels oxidative stress and chronic inflammation (Xu and Wen, 2023). This inflammatory state further impacts satellite cell function and disrupts proteostasis, creating a detrimental feedback loop. This interconnectedness emphasizes that effective interventions for sarcopenia must consider these synergistic relationships rather than targeting single pathways in isolation (Table 2).
Table 2. Interconnections between key hallmarks of aging, DNA damage, and sarcopenia.
3.2 Telomere attrition
Telomeres are protective caps at the ends of chromosomes that shorten with each cell division. In skeletal muscle, excessive telomere attrition, often accelerated by oxidative stress (a condition linked to DNA damage), can trigger cellular senescence in both muscle fibers and satellite cells. This senescence contributes directly to sarcopenia by halting regeneration and promoting a pro-inflammatory environment (SASP) (Iskandar et al., 2025; Erusalimsky, 2020; Nelke et al., 2019).
3.3 Epigenetic alterations
Aging is associated with widespread changes to the epigenome, including altered DNA methylation patterns and histone modifications. In muscle, these epigenetic drifts can improperly silence genes essential for muscle repair (e.g., myogenic differentiation genes) or activate genes involved in atrophy and fibrosis. These alterations can also impact the expression of DNA repair enzymes themselves, linking this hallmark back to genomic instability (Carrió and Suelves, 2015; Kane and Sinclair, 2019; An et al., 2020).
3.4 Loss of proteostasis and deregulated nutrient-sensing
Proteostasis, the balance of protein synthesis and degradation, is critical in muscle. Sarcopenia is marked by a loss of this balance, often driven by impaired anabolic signaling (e.g., “anabolic resistance” to protein or exercise) and increased catabolic pathway activity (Wiedmer et al., 2021; Paez et al., 2023). This is tightly linked to deregulated nutrient-sensing pathways, such as reduced insulin/IGF-1 signaling and altered mTOR and AMPK activity, which fail to properly signal for muscle protein synthesis and maintenance (Yang et al., 2023; Fernandes and Demetriades, 2021).
3.5 Mitochondrial dysfunction
Mitochondrial dysfunction stands as a pivotal mechanism in the pathogenesis of sarcopenia. The aging process induces oxidative stress, which in turn impairs mitochondrial function and reduces adenosine triphosphate (ATP) production, thereby compromising the energy supply critical for muscle cell activity (Lee et al., 2024). Mitochondria are the primary intracellular source of ROS in muscle, and excessive ROS production directly damages both mitochondrial DNA (mtDNA) and mitochondrial proteins, leading to further dysfunction and a perpetuation of the oxidative burden.
The accumulation of mtDNA damage, particularly deletions and point mutations, is strongly implicated in sarcopenia. These genomic insults within the mitochondria lead to impaired oxidative phosphorylation (OXPHOS) and a significant reduction in the activities of electron transport chain (ETC.) complexes (Alizadeh Pahlavani et al., 2022; Nadalutti et al., 2022). This bioenergetic failure directly contributes to the characteristic muscle weakness and fatigue observed in sarcopenic individuals (Xu and Wen, 2023; Affourtit and Carré, 2024).
Beyond direct damage, mitochondrial dynamics—the continuous processes of fission (division) and fusion (merging)—are also profoundly altered in sarcopenic muscle. This imbalance leads to the accumulation of dysfunctional organelles. Key proteins involved in mitochondrial fission, such as dynamin-related protein 1 (DRP1) and fission protein 1 (FIS1), are decreased in sarcopenia, impairing the isolation and removal of damaged mitochondria (Mao et al., 2021a; Mao et al., 2021b; Shi et al., 2023). Similarly, fusion proteins like mitofusin 1 (Mfn1), mitofusin 2 (Mfn2), and optic atrophy 1 (OPA1) are downregulated, compromising the redistribution of metabolites and mtDNA and leading to mitochondrial fragmentation and dysfunction (Li C. et al., 2023; Zheng et al., 2023). The impaired removal of damaged or dysfunctional mitochondria through mitophagy, a selective form of autophagy, further exacerbates this accumulation, ultimately activating apoptotic and necrotic pathways within muscle cells (Gao et al., 2025; Rafiyian et al., 2024). Concurrently, mitochondrial biogenesis, the process of forming new mitochondria, regulated by master factors such as peroxisome proliferator-activated receptor-gamma coactivator-1alpha (PGC-1alpha) and mitochondrial transcription factor A (TFAM), also declines with age in sarcopenia (Alizadeh Pahlavani et al., 2022).
The relationship between mitochondrial dysfunction, ROS production, and mtDNA damage in aging muscle forms a detrimental “vicious cycle”. Defective mitochondria generate more ROS, which in turn inflicts further damage upon mtDNA and mitochondrial proteins, leading to even greater mitochondrial dysfunction and ROS production. This self-amplifying loop creates a systemic energy deficit and oxidative burden that progressively propagates muscle weakness and atrophy (Gao et al., 2025). Breaking this vicious cycle through interventions that enhance mitochondrial quality control (biogenesis, dynamics, and mitophagy) and repair mtDNA is therefore paramount for mitigating sarcopenia.
3.6 Satellite cell exhaustion and impaired regeneration
Skeletal muscle possesses a remarkable capacity for regeneration, a process critically dependent on a specialized population of adult stem cells known as muscle satellite cells (MuSCs). However, a defining feature of muscle aging is a progressive decline in both the number and functional capacity of MuSCs, which significantly contributes to impaired muscle regeneration and, consequently, to the development of sarcopenia (Huo et al., 2022; Dowling et al., 2023).
Age-related MuSC dysfunction is often characterized by a shift from a reversible quiescent state to an irreversible senescent state (He et al., 2022; Wang et al., 2025; Sousa-Victor et al., 2014). The expression of p16INK4a is particularly important, as it plays a critical role in establishing and maintaining the irreversible nature of this senescent arrest (Beauséjour et al., 2003). This senescent phenotype is marked by the upregulation of cell cycle inhibitors, most notably p16INK4a (He et al., 2022). Cellular senescence itself is frequently triggered by the accumulation of DNA damage (Zhao et al., 2023a; Shmulevich and Krizhanovsky, 2021). Aged MuSCs exhibit an accumulation of ROS, and this overproduction, potentially stemming from altered mitochondrial function or compromised ROS management, is considered a contributing factor to sarcopenia (Huo et al., 2022; Wu et al., 2022). Aberrant signaling pathways, such as the p38 mitogen-activated protein kinase (MAPK) pathway, are also implicated in driving MuSC dysfunction (Mano et al., 2022; Sirago et al., 2022). Studies have shown that even transient systemic mitochondrial DNA (mtDNA) damage can lead to muscle wasting by reducing the satellite cell pool, underscoring the particular sensitivity of these critical stem cells to genomic insults (Wang et al., 2013).
3.7 Chronic low-grade inflammation (inflammaging) and proteostasis imbalance
Aging is universally associated with a state of chronic, low-grade, sterile inflammation, a phenomenon termed “inflammaging”. This persistent inflammatory state is characterized by elevated systemic levels of pro-inflammatory cytokines, including interleukin-1α (IL-1α), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α). Inflammaging is strongly linked to the pathogenesis and progression of sarcopenia (Lee et al., 2024; Wang, 2022; Antuña et al., 2022).
These inflammatory cytokines activate intracellular signaling pathways, most notably nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). Activated NF-κB, in turn, promotes skeletal muscle protein degradation by increasing the expression of muscle-specific E3 ubiquitin ligases, such as Muscle RING-finger Protein-1 (MURF-1) and Atrogin-1 (Brink, 2005; Peris-Moreno et al., 2021). Furthermore, these inflammatory mediators directly interfere with muscle cell regeneration (Chen et al., 2021; Panci and Chazaud, 2021).
A major driver of inflammaging is the Senescence-Associated Secretory Phenotype (SASP), a complex secretome released by senescent cells, which are often themselves a consequence of accumulated DNA damage (He et al., 2022; Saad et al., 2024; Acosta et al., 2008; Coppé et al., 2008). This SASP directly drives chronic low-grade inflammation (inflammaging), which in turn exacerbates muscle protein degradation and inhibits regeneration, thereby further contributing to sarcopenia (He et al., 2022; Alqahtani et al., 2025). This creates a damaging feedback loop where genomic instability fuels a systemic inflammatory environment that directly compromises muscle integrity. This highlights the broad, systemic impact of DNA damage on muscle health, extending beyond the muscle cell itself to influence the entire tissue microenvironment. The evidence reviewed here therefore suggests that interventions effectively reducing DNA damage or clear senescent cells could offer a dual benefit: directly improving genomic integrity and indirectly mitigating inflammaging, thus preserving muscle mass and function. Complementing this, the loss of proteostasis—an impaired balance between protein synthesis and degradation—is another critical hallmark of aging directly implicated in sarcopenia. While basal protein turnover rates may not differ substantially between young and old muscle, a blunting of the anabolic response to stimuli like feeding and exercise is observed in aging muscle, coupled with an overall increase in catabolism (Lee et al., 2024; Riuzzi et al., 2018).
3.8 Neuromuscular junction degeneration and altered intercellular communication
Changes occurring at the neuromuscular junction (NMJ) are increasingly recognized as a significant contributing factor to sarcopenia. The NMJ is the specialized synapse between a motor neuron and a muscle fiber, essential for transmitting nerve impulses that initiate muscle contraction. With aging, there is a progressive loss of motor neurons, leading to muscle fiber denervation and fragmentation of the NMJ, which profoundly impairs efficient neurotransmission (Deschenes et al., 2022; Arnold and Clark, 2023; Iyer et al., 2021).
Mitochondrial dysfunction and oxidative stress, both prominent features of muscle aging and sarcopenia, have been shown to directly damage components of the NMJ (Miao et al., 2024). At the molecular level, aging is associated with decreased levels of agrin and reduced activation of muscle-specific kinase (MuSK), both crucial for maintaining NMJ integrity (Ohkawara et al., 2021; Sun et al., 2024). The C-terminal Agrin fragment (CAF) has emerged as a promising biomarker for NMJ degeneration, with higher serum concentrations observed in older adults correlating with decreased muscle strength and sarcopenia (Monti et al., 2023; Pratt et al., 2021).
While the direct molecular link between exercise-induced DNA repair and NMJ integrity is not explicitly detailed in all available data, the fact that mitochondrial dysfunction and oxidative stress—conditions heavily influenced by DNA damage and repair—can damage NMJ components suggests an important indirect causal chain (Chai et al., 2021; Dobrowolny et al., 2021). This implies that improving genomic integrity and mitochondrial health through exercise could have a beneficial ripple effect, indirectly supporting NMJ stability and function. This offers a more holistic approach to combating sarcopenia by preserving the entire functional muscle unit. The identification of CAF as a potential biomarker and therapeutic target further underscores the translational potential of this research area, providing a measurable outcome for future interventions (Figure 2).
Figure 2. Genomic Instability and the Hallmarks of Sarcopenia. This schematic positions Genomic Instability as the primary driver initiating a multifactorial cascade that leads to muscle aging. The downstream consequences are categorized into distinct biological hallmarks: Genetic and Epigenetic Dysregulation: Telomere Attrition drives replicative senescence, while Epigenetic Alterations (e.g., methylation changes) skew gene expression toward atrophy rather than repair. Metabolic Impairment: Loss of Proteostasis and Deregulated Nutrient-Sensing (impacting mTOR/AMPK signaling) result in anabolic resistance. Concurrently, Mitochondrial Dysfunction creates a vicious cycle of ROS production and bioenergetic failure (reduced ATP). Regenerative and Signaling Failure: Satellite Cell Exhaustion depletes the pool of quiescent MuSCs, impairing regeneration. Cellular Senescence contributes to “inflammaging” via the secretion of SASP factors (e.g., IL-6, TNF-alpha). Additionally, Altered Intercellular Communication manifests as neuromuscular junction (NMJ) defects and denervation.Outcome: These converging pathways collectively result in Sarcopenia, defined by the loss of muscle mass, function, weakness, and fatigue (Image was drawn by Adobe illustrator).
4 Exercise as a double-edged sword: inducing damage and orchestrating repair
4.1 Acute exercise: a transient inducer of DNA damage and stress responses
Acute bouts of exercise, particularly those that are unaccustomed or performed at exhaustive intensities, inevitably disrupt cellular homeostasis, leading to a transient increase in reactive oxygen species (ROS) production. This surge in ROS culminates in oxidative stress and transient DNA damage within skeletal muscle. Measurable markers of this damage include increased DNA strand breaks (detectable by techniques like the TUNEL assay, which labels the ends of fragmented DNA) and elevated levels of oxidized DNA bases, such as 8-OHdG (Bou Saada et al., 2017; Wang F. et al., 2021; Bouviere et al., 2021). Furthermore, the phosphorylation of histone H2AX (γ-H2AX), a widely recognized biomarker for double-strand breaks (DSBs) and the activation of DNA repair mechanisms, also shows an immediate increase following high-intensity exercise (He et al., 2022; Bazargaliyev et al., 2024; Jean et al., 2023).
Crucially, this exercise-induced DNA damage is typically transient, with repair mechanisms restoring genomic integrity within 24–72 h post-exercise (Tryfidou et al., 2020). More importantly, this transient damage is not solely detrimental; it is increasingly recognized as a vital signaling molecule for skeletal muscle adaptations. The transient increase in DNA damage markers like 8-OHdG and γ-H2AX following acute exercise is not an indicator of pathology but rather a physiological trigger for adaptive responses (Ye et al., 2023). This controlled damage acts as a “danger-associated molecular pattern” (DAMP), initiating an immune response and promoting tissue regeneration (Bou Saada et al., 2017). This aligns with the concept of “hormesis,” which suggests that moderate levels of stress are necessary to induce adaptive responses and strengthen endogenous antioxidant defense systems (Schirrmacher, 2021; Erofeeva, 2022). The body “senses” this controlled damage as a signal to upregulate repair pathways and antioxidant defenses. This mechanistic understanding is critical for designing optimal exercise protocols: the objective is not to eliminate all exercise-induced damage, but rather to induce a sufficient, transient level of stress that activates these beneficial adaptive responses without overwhelming the cellular repair capacity, thereby promoting genomic resilience and overall muscle health. The challenge lies in identifying the optimal intensity and duration of exercise that maximizes these adaptive repair mechanisms without leading to chronic, detrimental damage.
4.2 Chronic exercise training: fortifying DNA repair systems and genomic resilience
In stark contrast to the transient effects of acute exercise, regular or chronic exercise training leads to profound and sustained adaptations that significantly enhance DNA repair kinetics and overall DNA repair capacity, thereby fortifying genomic resilience (Cobley et al., 2015; Sellami et al., 2021). Studies have consistently demonstrated that trained individuals exhibit a faster rate of repair for radiation-induced DNA strand breaks compared to their untrained counterparts (Moreno-Villanueva et al., 2019). However, it is critical to note that much of this evidence for enhanced repair kinetics has been generated from peripheral blood lymphocytes rather than directly from post-mitotic skeletal muscle. While informative, it remains to be definitively shown that these systemic enhancements in circulating cells fully reflect the specific adaptive changes within muscle fibers. Despite this limitation, some muscle-specific evidence does exist. Chronic exercise upregulates the expression and activity of specific DNA repair enzymes. For example, eight-oxoguanine-DNA glycosylase (OGG1), a crucial enzyme in the Base Excision Repair (BER) pathway responsible for excising the common oxidative lesion 8-OHdG, shows increased activity in skeletal muscle following both acute (e.g., after a marathon race) and regular exercise training (Radák et al., 2003). Furthermore, regular exercise not only increases nuclear OGG1 activity but also improves its import into the mitochondrial matrix, thereby augmenting the repair of both nuclear and mitochondrial DNA bases (Radak et al., 2009). Poly (ADP-ribose) polymerase-1 (PARP1), a key DNA damage sensor, is also influenced by exercise; while excessive exercise can lead to detrimental PARP1 overactivation, aerobic fitness is associated with lower endogenous PARP1 activity and provides protection against exercise-induced DNA strand breaks (Moreno-Villanueva et al., 2019). Beyond direct repair mechanisms, chronic exercise also significantly increases the overall endogenous antioxidant capacity, effectively reducing the burden of oxidative stress and damage (Fisher et al., 2025; Powers et al., 2022; Soares et al., 2015).
The observation that chronic exercise enhances DNA repair kinetics and upregulates specific repair enzymes like OGG1 signifies a fundamental adaptive plasticity of the genome maintenance system in response to repeated physical demands (Arkenberg and Dittmar, 2024; Blaze et al., 2022; Walczak et al., 2021; Lloyd, 2022; Zhong et al., 2024). This is not merely a transient response but a sustained improvement in the cell’s inherent ability to cope with genotoxic stress. This long-term genomic resilience represents a critical, yet often underappreciated, mechanism by which exercise confers its profound anti-aging benefits, extending beyond more commonly studied effects such as muscle hypertrophy or metabolic improvements. This enhanced repair capacity means that the muscle is better equipped to handle the daily burden of DNA damage, whether endogenous or exogenous. This directly contributes to maintaining genomic stability over the lifespan, thereby mitigating a primary hallmark of aging and offering a fundamental protective mechanism against sarcopenia. It suggests that exercise is not just a treatment for age-related muscle decline, but a powerful preventative measure that strengthens the cell’s intrinsic defense systems.
4.3 Molecular signaling cascades mediating exercise-induced muscle adaptation and supporting genomic homeostasis
Exercise-induced adaptive responses are orchestrated by complex and interconnected molecular signaling pathways that meticulously integrate metabolic and mechanical cues with gene expression and cellular function. These pathways are crucial for translating physical activity into beneficial cellular adaptations, including enhanced DNA repair and overall muscle health (Table 3, 4).
Table 3. Impact of acute and chronic exercise on DNA damage markers and repair enzyme activity in skeletal muscle.
Table 4. Key signaling pathways mediating exercise-induced muscle adaptation and indirectly supporting DNA repair capacity.
Key signaling pathways involved in linking exercise to DNA repair and muscle adaptation include.
• AMPK-SIRT1-FOXO Pathway: The AMP-activated protein kinase (AMPK) acts as a central cellular energy sensor, becoming activated when the AMP/ATP ratio increases during exercise. Activated AMPK, in turn, enhances the activity of SIRT1 (Sirtuin 1), a NAD + -dependent deacetylase, by increasing intracellular NAD + levels (Cantó et al., 2010). SIRT1 then deacetylates key transcriptional regulators such as PGC-1α and FOXO (Forkhead box O transcription factors), leading to the transcriptional modulation of genes involved in mitochondrial function and lipid utilization. This cascade collectively enhances mitochondrial function, reduces mitochondrial damage, and mitigates oxidative stress (Guan et al., 2025). Furthermore, FOXO transcription factors are known to regulate autophagy, a crucial process for the removal of damaged organelles and proteins (Bagam et al., 2021; Cheng, 2022).
• The Energy-Splicing Resilience Axis: A more recently proposed mechanism linking cellular energy status to adaptation is the ‘energy-splicing resilience axis’ (Ferrucci et al., 2022). This hypothesis posits that in conditions of low mitochondrial energy availability (common in aging and low fitness), cells activate a resilience strategy by upregulating the spliceosome machinery. This, in turn, produces alternative mRNA splicing variants of key proteins in an attempt to restore energetic homeostasis. This concept is strongly supported by recent muscle transcriptomic and proteomic studies. For instance, skeletal muscle from older, low-fitness individuals shows enhanced alternative splicing and an upregulation of splicing-related pathways, whereas physically active individuals show the opposite: higher mitochondrial protein content and lower levels of splicing-related proteins (Ferrucci et al., 2022; Donega et al., 2025). This axis is thought to be mediated by the same key energy sensors discussed in this section, with evidence pointing to AMPK signaling as a direct regulator of splicing factor activity (Ferrucci et al., 2022). This concept is strongly supported by recent muscle transcriptomic and proteomic studies. For instance, recent work by Brandon et al. (2025) demonstrated that ad libitum-fed diets matching the lifespan benefits of caloric restriction act via opposite effects on this energy-splicing axis, highlighting its pivotal role in longevity and metabolic resilience (Brandon et al., 2025).
• PGC-1α Pathway: Peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α) is widely regarded as a master regulator of mitochondrial biogenesis and a fundamental component of exercise-induced adaptations in skeletal muscle (Kong et al., 2022; de Smalen et al., 2023; Xiao et al., 2021). PGC-1α is induced by oxidative stress and plays a critical role in regulating ROS removal. Exercise upregulates PGC-1α expression, which promotes oxidative fiber formation, improves exercise performance, and contributes to increases in muscle mass and strength (Zuo et al., 2023; Liu et al., 2021).
• Nrf2 Pathway: Nuclear factor erythroid 2-related factor 2 (Nrf2) is a vital antioxidant factor responsible for maintaining intracellular redox homeostasis. The AMPK-PGC-1α axis can lead to the upregulation of Nrf2, thereby improving mitochondrial function and enhancing cellular resilience against oxidative damage (Guan et al., 2025).
• mTORC1 Signaling: Resistance exercise is a potent stimulator of the mammalian target of rapamycin complex 1 (mTORC1) activity. This activation promotes significant increases in muscle protein synthesis, leading to muscle hypertrophy (Basharat et al., 2012). While primarily known for its role in protein synthesis, mTORC1 also influences mitochondrial biogenesis (Bou Saada et al., 2017).
• NF-κB and AP-1 Pathways: During moderate exercise, ROS function as signaling molecules, activating several pathways including NF-κB (nuclear factor-κB) and AP-1. These pathways directly stimulate the expression of various antioxidant genes, such as superoxide dismutase (SOD) and glutathione peroxidase (GPX) (Bou Saada et al., 2017). However, it is important to note that chronic inflammation also activates NF-κB, which can paradoxically promote muscle protein degradation (Wu et al., 2021; Ji et al., 2022).
The intricate cross-talk between pathways like AMPK-SIRT1-FOXO, PGC-1α, Nrf2, mTORC1, and the recently proposed energy-splicing resilience axis, reveals that exercise does not simply activate isolated pathways but orchestrates a highly integrated regulatory network (Guan et al., 2025; Ferrucci et al., 2022; Athari et al., 2023). This network simultaneously enhances DNA repair, boosts antioxidant defenses, promotes mitochondrial biogenesis and quality control, modulates mRNA splicing, and finely tunes protein turnover. This synergistic action provides a comprehensive explanation for how exercise can exert such broad and profound anti-sarcopenic effects, by targeting multiple interconnected hallmarks of aging at a fundamental molecular level. These adaptations create a cellular environment that is less prone to damage and more conducive to efficient DNA repair (e.g., by reducing oxidative damage burden and improving overall cellular homeostasis). This synergistic action is key to exercise’s effectiveness as a comprehensive anti-sarcopenic intervention.
5 Exercise-induced DNA damage repair: a therapeutic avenue for sarcopenia
5.1 Direct contributions to maintaining genomic stability in aged myocytes
Exercise-enhanced DNA repair directly counteracts the pervasive age-related accumulation of genomic lesions within skeletal muscle (Rebelo-Marques et al., 2018). By augmenting the activity of critical repair enzymes, such as eight-oxoguanine-DNA glycosylase (OGG1), and by improving overall DNA repair kinetics, regular physical activity plays a fundamental role in maintaining the integrity of both nuclear and mitochondrial DNA (Soares et al., 2015). This reduction in the overall DNA damage load is fundamental to preserving cellular function and preventing the onset of age-related cellular dysfunction (Maynard et al., 2015).
The direct enhancement of DNA repair capacity by exercise signifies a fundamental mechanism by which exercise combats aging at its very core. Given that genomic instability is recognized as a primary hallmark of aging, exercise’s ability to directly improve DNA repair means it is not merely treating the symptoms of sarcopenia but is addressing one of its root causes (Li Z. et al., 2023; Veschetti et al., 2023; Marqueze et al., 2023). This has profound implications for cellular longevity and the sustained functional maintenance of muscle tissue, extending beyond simple muscle hypertrophy. By directly reversing or attenuating the age-related accumulation of DNA damage, exercise acts as a powerful “anti-aging” intervention at the molecular level, contributing to the healthy longevity of muscle cells and, consequently, delaying the onset and progression of sarcopenia.
5.2 Restoring mitochondrial health and bioenergetic capacity
Exercise-induced DNA damage repair plays a crucial and multifaceted role in maintaining and restoring mitochondrial health, a central determinant of muscle function and a key factor in sarcopenia pathogenesis (Alizadeh Pahlavani et al., 2022; Za et al., 2021). By augmenting the repair of mitochondrial DNA (mtDNA), for instance, through improved import of OGG1 into the mitochondrial matrix, exercise effectively reduces the accumulation of damaged mtDNA. This is critical because mtDNA damage is a primary driver of mitochondrial dysfunction and a significant contributor to sarcopenia (Alizadeh Pahlavani et al., 2022; Radak et al., 2009).
Beyond direct repair, exercise orchestrates a comprehensive suite of adaptations that collectively improve mitochondrial quality and function. It enhances mitochondrial biogenesis (the formation of new mitochondria), balances mitochondrial dynamics (the continuous processes of fission and fusion), and promotes mitophagy (the selective clearance of damaged or dysfunctional mitochondria) (Alizadeh Pahlavani et al., 2022; Sorriento et al., 2021). These processes are often regulated by key signaling pathways such as AMPK and PGC-1α. The culmination of these adaptations is a healthier, more efficient mitochondrial pool, leading to improved ATP production and a reduction in detrimental oxidative stress. This directly mitigates the muscle weakness and fatigue characteristic of sarcopenia (Riuzzi et al., 2018).
The ability of exercise to enhance mtDNA repair, coupled with its effects on mitochondrial biogenesis, dynamics, and mitophagy, represents a comprehensive molecular cascade that directly addresses the “vicious cycle” of mitochondrial dysfunction in sarcopenia (Gao et al., 2025; Zhu et al., 2023). This integrated approach leads to a significant improvement in bioenergetic capacity, which is directly translated into enhanced muscle strength and endurance. This demonstrates how molecular interventions, driven by physical activity, can effectively restore physiological function in aging muscle.
5.3 Preserving satellite cell function and regenerative potential
Exercise plays a critical role in preserving the function and regenerative potential of muscle satellite cells (MuSCs), the resident stem cells of skeletal muscle (Widodo et al., 2022; Fukada and Nakamura, 2021). While age-related MuSC exhaustion is a significant contributor to sarcopenia, often triggered by accumulated DNA damage and the induction of cellular senescence, exercise can effectively mitigate these detrimental effects (Wang et al., 2013).
By actively reducing systemic oxidative stress and inflammation—both of which are known to induce senescence and impair MuSC function—exercise creates a more favorable microenvironment for MuSCs (Canals-Garzón et al., 2022; Thirupathi et al., 2021; El Assar et al., 2022). Although specific direct evidence for exercise-induced DNA repair within satellite cells is not explicitly detailed in all available data, the broader effects of exercise on reducing systemic oxidative stress and inflammation are crucial for maintaining a healthy stem cell niche. The Senescence-Associated Secretory Phenotype (SASP), released by senescent cells (which are often induced by DNA damage), is known to disrupt this niche (Kumari and Jat, 2021; Ohtani, 2022; Chambers et al., 2021). Therefore, exercise’s ability to enhance DNA repair and reduce the burden of senescent cells indirectly protects MuSCs by creating a less hostile environment. This preservation of MuSC genomic integrity and function helps maintain their proliferative and differentiation capacities, thereby supporting ongoing muscle repair and hypertrophy (Kuipers, 1994). This implies that exercise does not just act on mature muscle fibers but also protects the regenerative engine of the muscle, ensuring a sustained capacity for repair and adaptation throughout aging, which is vital for long-term sarcopenia prevention (Figure 3).
Figure 3. Mechanisms of Exercise-Induced Benefits on Aged Skeletal Muscle. This schematic details the pleiotropic effects of exercise in counteracting muscle aging. (5.1) Genomic Stability. Exercise enhances the expression of DNA repair enzymes (e.g., OGG1) in aged myocytes, leading to the repair of nuclear DNA, a reduction in genomic lesions, and the preservation of cellular function. (5.2) Mitochondrial Health and Bioenergetics. Physical activity stimulates mtDNA repair, biogenesis, and mitophagy. This results in improved mitochondrial quality, increased ATP production, and reduced ROS levels, collectively enhancing bioenergetic capacity and muscle strength. (5.3) Satellite Cell Function. Exercise reduces oxidative stress and inflammation (SASP), preventing the senescence of satellite cells (MuSCs). This preserves their proliferative capacity and ensures sustained regenerative potential. Overall Outcome. These converging pathways result in the prevention of sarcopenia and the promotion of healthy muscle aging (image was drawn by adobe illustrator).
6 Critical gaps, unresolved questions, and future research imperatives
Despite significant advancements in understanding the impact of exercise on DNA damage repair and its implications for sarcopenia, several critical gaps and unresolved questions persist, necessitating focused future research.
6.1 Dissecting the specificity of exercise modalities on DNA repair pathways
Current literature often provides a generalized view of “exercise” effects on DNA damage and repair. However, the distinct physiological demands imposed by different exercise modalities (e.g., the metabolic stress of endurance training versus the mechanical stress of resistance training), varying intensities (e.g., moderate-intensity continuous exercise versus high-intensity interval training), and diverse durations likely engage unique signaling cascades and, consequently, distinct DNA repair pathways or their components. For instance, resistance exercise is known to induce more muscle damage yet also produces greater muscle hypertrophy than aerobic exercise (Ye et al., 2023). A critical gap exists in systematically dissecting how these specific stimuli differentially activate or suppress individual DNA repair mechanisms, such as Base Excision Repair (BER), Nucleotide Excision Repair (NER), Homologous Recombination (HR), and Non-Homologous End Joining (NHEJ) in skeletal muscle (Shamsnia et al., 2023). This detailed knowledge is paramount for moving towards personalized exercise prescriptions that optimally leverage specific DNA repair mechanisms to combat sarcopenia, rather than relying on a generalized, one-size-fits-all approach. Future studies should employ sophisticated molecular techniques to map the activation and efficiency of each repair pathway in response to precisely controlled exercise interventions.
6.2 Moving from static markers to repair kinetics
A major limitation in the current field, as this review highlights, is the reliance on static measurements, such as the basal levels of repair enzymes or the accumulation of lesions (e.g., 8-OHdG). These markers do not adequately capture the dynamic process or functional capacity of repair. Future research must adopt more sophisticated methods to measure the kinetics of DNA repair directly within muscle tissue. This includes quantifying the appearance and disappearance of nuclear foci that mark specific lesions, such as γH2AX for double-strand breaks (Rogakou et al., 1999), or using advanced microscopy with fluorescently-tagged proteins, such as FEN1-YFP for base excision repair (Kleppa et al., 2012), to visualize protein recruitment and turnover at damage sites in vivo. Such kinetic studies are essential to definitively prove that chronic exercise enhances the efficiency of DNA repair in aging muscle, rather than just altering the baseline expression of repair-related genes.
6.3 Longitudinal studies and human translation
Much of the foundational understanding of exercise-induced DNA damage and repair mechanisms derives from animal models or acute human studies. There is a pressing need for more robust, long-term longitudinal human studies to confirm these findings and to fully elucidate the chronic adaptive responses in diverse aging populations (Cartee et al., 2016). Such studies should ideally include a wide range of age groups, fitness levels, and health statuses to capture the full spectrum of individual variability in response to exercise. Understanding how chronic exercise impacts DNA repair capacity over decades, and how this translates into long-term functional outcomes in muscle, remains largely unexplored.
6.4 Biomarker development for DNA damage and repair in muscle
The development of reliable, non-invasive, and muscle-specific biomarkers for monitoring DNA damage and repair in vivo is crucial (Gao et al., 2025). While markers like 8-OHdG and γH2AX are used, their specificity and sensitivity for skeletal muscle damage and repair, especially in a clinical context, require further validation (Bou Saada et al., 2017). The C-terminal Agrin fragment (CAF) shows promise as a marker for neuromuscular junction degeneration (Monti et al., 2023; Pratt et al., 2021), but a broader panel of markers is needed. This panel should ideally extend beyond direct damage markers to include metabolic signatures that reflect cellular stress, recovery, and resilience. For instance, recent studies focusing on continuous blood sampling dynamics during acute exercise and recovery have successfully mapped real-time metabolomic changes, revealing distinct profiles in lipid and bile acid clearance between high- and low-fitness individuals (Fountain et al., 2025). Applying similar high-frequency profiling methods to capture the dynamics of DNA repair byproducts or related metabolic shifts could enable precise monitoring of intervention efficacy, facilitate early diagnosis of sarcopenia, and allow for personalized exercise prescriptions based on an individual’s genomic resilience.
6.5 Interplay with other hallmarks of aging
A comprehensive understanding of sarcopenia requires elucidating the complex cross-talk and feedback loops between exercise-induced DNA repair and these other hallmarks. For instance, how does enhanced DNA repair influence epigenetic modifications that regulate muscle gene expression, or how does it modulate the senescence-associated secretory phenotype (SASP) to reduce inflammaging and preserve the stem cell niche? Future research should adopt systems biology approaches, integrating multi-omics data (genomics, epigenomics, proteomics, metabolomics) to unravel these intricate relationships and identify novel therapeutic targets.
6.6 Genetic and epigenetic modifiers of exercise response
The response to exercise is highly individualized, with significant variability observed among individuals (Escriche-Escuder et al., 2021). This variability is influenced by both genetic predisposition and epigenetic factors (Widmann et al., 2019). Future research should investigate how genetic polymorphisms in DNA repair genes or exercise-responsive signaling pathways, as well as individual epigenetic landscapes, modulate the capacity for exercise-induced DNA repair and subsequent muscle adaptation. This knowledge is essential for developing truly personalized exercise strategies that maximize benefits for each individual, moving beyond generalized recommendations.
6.7 Therapeutic interventions beyond exercise
While exercise is a cornerstone of sarcopenia management, its efficacy can be constrained by factors such as long-term adherence and variable individual responses. This highlights the need for comprehensive and personalized treatment strategies, including potential pharmacological or nutritional interventions that could synergize with exercise to enhance DNA repair or mitigate sarcopenia. Research should explore compounds that directly enhance DNA repair enzyme activity, reduce oxidative stress, or clear senescent cells, and then test their combined effects with exercise in preclinical and clinical settings. This could lead to novel multi-modal therapies that amplify the anti-sarcopenic benefits of physical activity (Figure 4).
Figure 4. Unresolved Questions and Future Directions in Exercise-Mediated DNA Repair for Sarcopenia. This schematic outlines the critical knowledge gaps and necessary research avenues to optimize therapeutic interventions for muscle aging. (6.1) Exercise Modality Specificity. Future research must define how distinct training types—endurance, resistance, and HIIT—differentially activate specific DNA repair pathways, such as BER, NER, HR, and NHEJ. (6.2) Repair Kinetics. Moving beyond static measurements of basal levels, studies need to evaluate dynamic repair rates and real-time functional capacity. (6.3–6.4) Monitoring and Validation. Longitudinal human studies are required to confirm chronic adaptations across diverse populations, alongside the development of non-invasive, muscle-specific biomarkers for easier monitoring. (6.5) Interplay with Aging Hallmarks. It is crucial to elucidate the complex cross-talk and feedback loops between DNA repair and other aging mechanisms, including epigenetics, mitochondrial dysfunction, stem cell exhaustion, and senescence (SASP). (6.6–6.7) Personalization and Synergy. Finally, the field must address individual variability driven by genetic and epigenetic modifiers (e.g., SNPs) to personalize treatments, while exploring synergistic combinations of exercise with pharmaceutical or nutritional interventions to maximally reduce sarcopenia.
7 Conclusion
Sarcopenia represents a formidable challenge to healthy aging, characterized by a progressive decline in muscle mass and strength that profoundly impacts quality of life and increases healthcare burdens. At its molecular core, aging muscle is plagued by accumulating DNA damage and impaired DNA repair, a manifestation of genomic instability—a fundamental hallmark of aging. This review has examined how this genomic vulnerability contributes to sarcopenia through a complex interplay with mitochondrial dysfunction, satellite cell exhaustion, chronic inflammation (inflammaging), and neuromuscular junction degeneration.
Paradoxically, physical exercise, while transiently inducing DNA damage, acts as a powerful orchestrator of cellular repair and adaptation. Chronic exercise training fortifies the DNA repair machinery, upregulating key enzymes like OGG1 and enhancing overall repair kinetics in skeletal muscle. This exercise-induced genomic resilience is mediated by intricate signaling cascades, including the AMPK-SIRT1-FOXO, PGC-1α, Nrf2, and mTORC1 pathways, which synergistically enhance mitochondrial health, boost antioxidant defenses, and support muscle protein turnover and regeneration. By directly counteracting DNA damage accumulation and indirectly mitigating other pro-sarcopenic hallmarks, exercise-induced DNA damage repair emerges as a fundamental therapeutic avenue for preserving muscle function and combating age-related muscle weakness. In essence, exercise is not merely a physical activity but a profound biological intervention that fundamentally reprograms cellular resilience by enhancing DNA damage repair. Continued, precise research into this intricate molecular axis, addressing the critical gaps outlined in this review, will be instrumental in unlocking the full therapeutic potential of exercise, ultimately fostering healthy muscle aging and improving the quality of life for an increasingly aging global population.
Author contributions
LZ: Data curation, Methodology, Supervision, Conceptualization, Validation, Writing – original draft, Writing – review and editing. YS: Data curation, Methodology, Formal Analysis, Validation, Visualization, Writing – original draft, Writing – review and editing. ZS: Data curation, Methodology, Supervision, Conceptualization, Project administration, Funding acquisition, Writing – original draft, Writing – review and editing.
Funding
The author(s) declared that financial support was not received for this work and/or its publication.
Acknowledgements
Figures were generated from adapted figures provided by Servier Medical Art (Servier; https://smart.servier.com/), licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). We also acknowledge Canva Pty Ltd (Sydney, Australia) for supplying design software that facilitated the creation of figures; all graphical content remains the original work of the authors.
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that generative AI was used in the creation of this manuscript. During the preparation of this work, the authors used Grok and ChatGPT in order to improve the writing process and to enhance the readability and language of the manuscript. After using this tool/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., et al. (2008). Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133 (6), 1006–1018. doi:10.1016/j.cell.2008.03.038
Affourtit, C., and Carré, J. E. (2024). Mitochondrial involvement in sarcopenia. Acta Physiol. 240 (3), e14107. doi:10.1111/apha.14107
Alghoul, E., Basbous, J., and Constantinou, A. (2023). Compartmentalization of the DNA damage response: mechanisms and functions. DNA Repair 128, 103524. doi:10.1016/j.dnarep.2023.103524
Alizadeh Pahlavani, H., Laher, I., Knechtle, B., and Zouhal, H. (2022). Exercise and mitochondrial mechanisms in patients with sarcopenia. Front. Physiology 13, 1040381. doi:10.3389/fphys.2022.1040381
Almohaisen, N., Gittins, M., Todd, C., Sremanakova, J., Sowerbutts, A. M., Aldossari, A., et al. (2022). Prevalence of undernutrition, frailty and sarcopenia in community-dwelling people aged 50 years and above: systematic review and meta-analysis. Nutrients 14 (8), 1537. doi:10.3390/nu14081537
Alqahtani, S., Alqahtani, T., Venkatesan, K., Sivadasan, D., Ahmed, R., Sirag, N., et al. (2025). SASP modulation for cellular rejuvenation and tissue homeostasis: therapeutic strategies and molecular insights. Cells 14 (8), 608. doi:10.3390/cells14080608
An, Y., Wang, Q., Gao, K., Zhang, C., Ouyang, Y., Li, R., et al. (2020). Epigenetic regulation of aging and its rejuvenation. MedComm 6 (9), e70369. doi:10.1002/mco2.70369
Antuña, E., Cachán-Vega, C., Bermejo-Millo, J. C., Potes, Y., Caballero, B., Vega-Naredo, I., et al. (2022). Inflammaging: implications in sarcopenia. Int. Journal Molecular Sciences 23 (23), 15039. doi:10.3390/ijms232315039
Arkenberg, P., and Dittmar, M. (2024). The 24-h profile of the DNA repair enzyme 8-oxoguanine glycosylase 1 (OGG1) is associated with age, TNF-α, and waist circumference in healthy adults. GeroScience 46 (2), 2489–2502. doi:10.1007/s11357-023-01012-z
Arnold, W. D., and Clark, B. C. (2023). Neuromuscular junction transmission failure in aging and sarcopenia: the nexus of the neurological and muscular systems. Ageing Research Reviews 89, 101966. doi:10.1016/j.arr.2023.101966
Athari, S. Z., Farajdokht, F., Keyhanmanesh, R., and Mohaddes, G. (2023). AMPK signaling pathway as a potential therapeutic target for Parkinson’s disease. Adv. Pharm. Bull. 14 (1), 120–131. doi:10.34172/apb.2024.013
Bagam, P., Kaur, G., Singh, D. P., and Batra, S. (2021). In vitro study of the role of FOXO transcription factors in regulating cigarette smoke extract-induced autophagy. Cell Biol. Toxicol. 37, 531–553. doi:10.1007/s10565-020-09556-y
Basharat, A., Naeem, A., Basharat, Z., and Qamar, M. (2012). A systematic review on the effectiveness of exercise in sarcopenia. J. Public Health Biol. Sci. 1, 61–67.
Bazargaliyev, Y., Kudabayeva, K., Zhexenova, A., Almagambetova, A., and Zame, Y. (2024). Analysis and quantification of double-stranded DNA breaks in blood lymphocytes by detection of γ-H2AX foci during a body mass increase. Obes. Med. 47, 100540. doi:10.1016/j.obmed.2024.100540
Beauséjour, C. M., Krtolica, A., Galimi, F., Narita, M., Lowe, S. W., Yaswen, P., et al. (2003). Reversal of human cellular senescence: roles of the p53 and p16 pathways. Embo J. 22 (16), 4212–4222. doi:10.1093/emboj/cdg417
Bilal, M., Maqbool, T., Wasim, M., Tariq, W., and Parveen, B. (2024). A review on DNA damaging patterns and repair mechanisms: DNA damage and repair mechanisms. Biol. Sciences-PJSIR 67 (2), 190–201.
Blaze, B., Marfo, E., and Sampath, H. (2022). Overexpression of human OGG1 improves skeletal muscle endurance in mice. FASEB J. 36. doi:10.1096/fasebj.2022.36.s1.l7942
Bordin, D. L., Lirussi, L., and Nilsen, H. (2021). Cellular response to endogenous DNA damage: DNA base modifications in gene expression regulation. DNA Repair 99, 103051. doi:10.1016/j.dnarep.2021.103051
Bou Saada, Y., Zakharova, V., Chernyak, B., Dib, C., Carnac, G., Dokudovskaya, S., et al. (2017). Control of DNA integrity in skeletal muscle under physiological and pathological conditions. Cell Mol. Life Sci. 74 (19), 3439–3449. doi:10.1007/s00018-017-2530-0
Bouviere, J., Fortunato, R. S., Dupuy, C., Werneck-de-Castro, J. P., Carvalho, D. P., and Louzada, R. A. (2021). Exercise-stimulated ROS sensitive signaling pathways in skeletal muscle. Antioxidants 10 (4), 537. doi:10.3390/antiox10040537
Brandon, A. E., Pulpitel, T., Schmitz-Peiffer, C., Small, L., Senior, A. M., Stonehouse, S., et al. (2025). An Ad libitum-fed diet that matches the beneficial lifespan effects of caloric restriction but acts via opposite effects on the energy-splicing axis. Aging Cell 24, e70269. doi:10.1111/acel.70269
Brink, M. (2005). “The ubiquitin-proteasome pathway,” in Pharmacotherapy of cachexia. New York: CRC Press, 527–558.
Canals-Garzón, C., Guisado-Barrilao, R., Martínez-García, D., Chirosa-Ríos, I. J., Jerez-Mayorga, D., and Guisado-Requena, I. M. (2022). Effect of antioxidant supplementation on markers of oxidative stress and muscle damage after strength exercise: a systematic review. Int. Journal Environmental Research Public Health 19 (3), 1803. doi:10.3390/ijerph19031803
Cantó, C., Jiang, L. Q., Deshmukh, A. S., Mataki, C., Coste, A., Lagouge, M., et al. (2010). Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab. 11 (3), 213–219. doi:10.1016/j.cmet.2010.02.006
Careccia, G., Mangiavini, L., and Cirillo, F. (2023). Regulation of satellite cells functions during skeletal muscle regeneration: a critical step in physiological and pathological conditions. Int. J. Mol. Sci. 25 (1), 512. doi:10.3390/ijms25010512
Carrió, E., and Suelves, M. (2015). DNA methylation dynamics in muscle development and disease. Front. Aging Neurosci., 7–2015.
Cartee, G. D., Hepple, R. T., Bamman, M. M., and Zierath, J. R. (2016). Exercise promotes healthy aging of skeletal muscle. Cell Metab. 23 (6), 1034–1047. doi:10.1016/j.cmet.2016.05.007
Chai, S., Zhang, N., Cui, C., Bao, Z., Wang, Q., Lin, W., et al. (2021). Systematic review of mitochondrial dysfunction and oxidative stress in aging: a focus on neuromuscular junctions. Neural Regen. Res. 10, 4103.
Chambers, C. R., Ritchie, S., Pereira, B. A., and Timpson, P. (2021). Overcoming the senescence-associated secretory phenotype (SASP): a complex mechanism of resistance in the treatment of cancer. Mol. Oncology 15 (12), 3242–3255. doi:10.1002/1878-0261.13042
Chatterjee, N., and Walker, G. C. (2017). Mechanisms of DNA damage, repair, and mutagenesis. Environ. Mol. Mutagen 58 (5), 235–263. doi:10.1002/em.22087
Chen, X., Hodges, P. W., James, G., and Diwan, A. D. (2021). Do markers of inflammation and/or muscle regeneration in lumbar multifidus muscle and fat differ between individuals with good or poor outcome following microdiscectomy for lumbar disc herniation? Spine. Spine Phila. pa. 1976. 46 (10), 678–686. doi:10.1097/BRS.0000000000003863
Cheng, Z. (2022). FoxO transcription factors in mitochondrial homeostasis. Biochem. J. 479 (4), 525–536. doi:10.1042/BCJ20210777
Cobley, J. N., Margaritelis, N. V., Morton, J. P., Close, G. L., Nikolaidis, M. G., and Malone, J. K. (2015). The basic chemistry of exercise-induced DNA oxidation: oxidative damage, redox signaling, and their interplay. Front. Physiology 6, 6–2015. doi:10.3389/fphys.2015.00182
Colleluori, G., and Villareal, D. T. (2021). Aging, obesity, sarcopenia and the effect of diet and exercise intervention. Exp. Gerontol. 155, 111561. doi:10.1016/j.exger.2021.111561
Coppé, J. P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., et al. (2008). Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6 (12), 2853–2868. doi:10.1371/journal.pbio.0060301
de Almeida, AJPO, de Oliveira, JCPL, da Silva Pontes, L. V., de Souza Júnior, J. F., Gonçalves, T. A. F., Dantas, S. H., et al. (2022). ROS: basic concepts, sources, cellular signaling, and its implications in aging pathways. Oxidative Medicine Cellular Longevity 2022 (1), 1225578. doi:10.1155/2022/1225578
Deschenes, M. R., Flannery, R., Hawbaker, A., Patek, L., and Mifsud, M. (2022). Adaptive remodeling of the neuromuscular junction with aging. Cells 11 (7), 1150. doi:10.3390/cells11071150
de Smalen, L. M., Börsch, A., Leuchtmann, A. B., Gill, J. F., Ritz, D., Zavolan, M., et al. (2023). Impaired age-associated mitochondrial translation is mitigated by exercise and PGC-1α. Proc. Natl. Acad. Sci. 120 (36), e2302360120. doi:10.1073/pnas.2302360120
Dobrowolny, G., Barbiera, A., Sica, G., and Scicchitano, B. M. (2021). Age-related alterations at neuromuscular junction: role of oxidative stress and epigenetic modifications. Cells 10 (6), 1307. doi:10.3390/cells10061307
Donega, S., Banskota, N., Gupta, E., Gonzalez-Freire, M., Moore, A. Z., Ubaida-Mohien, C., et al. (2025). Skeletal muscle mRNA splicing variants Association with four different fitness and energetic measures in the GESTALT study. J. Cachexia Sarcopenia Muscle 16 (1), e13603. doi:10.1002/jcsm.13603
Dowling, P., Gargan, S., Swandulla, D., and Ohlendieck, K. (2023). Fiber-type shifting in sarcopenia of old age: proteomic profiling of the contractile apparatus of skeletal muscles. Int. J. Mol. Sci. 24 (3), 2415. doi:10.3390/ijms24032415
El Assar, M., Álvarez-Bustos, A., Sosa, P., Angulo, J., and Rodríguez-Mañas, L. (2022). Effect of physical activity/exercise on oxidative stress and inflammation in muscle and vascular aging. Int. Journal Molecular Sciences 23 (15), 8713. doi:10.3390/ijms23158713
Erofeeva, E. A. (2022). Environmental hormesis: from cell to ecosystem. Curr. Opin. Environ. Sci. and Health 29, 100378. doi:10.1016/j.coesh.2022.100378
Erusalimsky, J. D. (2020). Oxidative stress, telomeres and cellular senescence: what non-drug interventions might break the link. Free Radic. Biol. Med. 150, 87–95. doi:10.1016/j.freeradbiomed.2020.02.008
Escriche-Escuder, A., Fuentes-Abolafio, I. J., Roldan-Jimenez, C., and Cuesta-Vargas, A. I. (2021). Effects of exercise on muscle mass, strength, and physical performance in older adults with sarcopenia: a systematic review and meta-analysis according to the EWGSOP criteria. Exp. Gerontology 151, 111420. doi:10.1016/j.exger.2021.111420
Fernandes, S. A., and Demetriades, C. (2021). The multifaceted role of nutrient sensing and mTORC1 signaling in physiology and aging. Front. Aging 2, 707372. doi:10.3389/fragi.2021.707372
Ferrucci, L., Wilson, D. M., Donegà, S., and Gorospe, M. (2022). The energy-splicing resilience axis hypothesis of aging. Nat. Aging. 2 (3), 182–185. doi:10.1038/s43587-022-00189-w
Fisher, G., Tamhane, A., Moellering, D. R., Behrens, C. E., and Hunter, G. R. (2025). Association between antioxidant capacity and vascular hemodynamics in premenopausal women following exercise training. J. Clin. Hypertens. 27 (4), e70046. doi:10.1111/jch.70046
Fountain, W. A., Donega, S., Banskota, N., Moaddel, R., Patel, M., Zukley, L., et al. (2025). Plasma longitudinal metabolic changes with acute maximal aerobic exercise and one-hour recovery. Front. Mol. Biosci., 12–2025.
Fukada, S.-i., and Nakamura, A. (2021). Exercise/resistance training and muscle stem cells. Endocrinol. Metabolism 36 (4), 737–744. doi:10.3803/EnM.2021.401
Gao, J., and Pickett, H. A. (2022). Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies. Nat. Rev. Cancer 22 (9), 515–532. doi:10.1038/s41568-022-00490-1
Gao, Y., Liu, D., Xiao, Q., Huang, S., Li, L., Xie, B., et al. (2025). Exploration of pathogenesis and cutting-edge treatment strategies of Sarcopenia: a narrative review. Clin. Interventions Aging 20, 659–684. doi:10.2147/CIA.S517833
Gartner, A., and Engebrecht, J. (2022). DNA repair, recombination, and damage signaling. Genetics 220 (2), iyab178. doi:10.1093/genetics/iyab178
Gensler, H. L., and Bernstein, H. (1981). DNA damage as the primary cause of aging. Q. Review Biology 56 (3), 279–303. doi:10.1086/412317
Goodfield, L. F., and Tsurumi, A. (2024). Characterizing the first 6-Year Hospital data for Sarcopenia using its first international classification of diseases (ICD-10-CM) diagnosis code.
Guan, G., Chen, Y., and Dong, Y. (2025). Unraveling the AMPK-SIRT1-FOXO pathway: the In-Depth analysis and breakthrough prospects of oxidative stress-induced diseases. Antioxidants 14 (1), 70. doi:10.3390/antiox14010070
He, F., Li, J., Liu, Z., Chuang, C.-C., Yang, W., and Zuo, L. (2016). Redox mechanism of reactive oxygen species in exercise. Front. Physiology 7, 7–2016. doi:10.3389/fphys.2016.00486
He, Y., Xie, W., Li, H., Jin, H., Zhang, Y., and Li, Y. (2022). Cellular senescence in Sarcopenia: possible mechanisms and therapeutic potential. Front. Cell Dev. Biol. 9, 9–2021. doi:10.3389/fcell.2021.793088
Huo, F., Liu, Q., and Liu, H. (2022). Contribution of muscle satellite cells to sarcopenia. Front. Physiology 13, 892749. doi:10.3389/fphys.2022.892749
Iskandar, M., Xiao Barbero, M., Jaber, M., Chen, R., Gomez-Guevara, R., Cruz, E., et al. (2025). A review of telomere attrition in cancer and aging: current molecular insights and future therapeutic approaches. Cancers 17 (2), 257. doi:10.3390/cancers17020257
Iyer, S. R., Shah, S. B., and Lovering, R. M. (2021). The neuromuscular junction: roles in aging and neuromuscular disease. Int. Journal Molecular Sciences 22 (15), 8058. doi:10.3390/ijms22158058
Jean, W.-H., Hsieh, Y.-W., Lai, L.-F., Dewi, L., Liao, Y.-C., Ye, M., et al. (2023). Senolytic effect of high intensity interval exercise on human skeletal muscle. Aging (Albany NY) 15 (3), 765–776. doi:10.18632/aging.204511
Ji, Y., Li, M., Chang, M., Liu, R., Qiu, J., Wang, K., et al. (2022). Inflammation: roles in skeletal muscle atrophy. Antioxidants 11 (9), 1686. doi:10.3390/antiox11091686
Kane, A. E., and Sinclair, D. A. (2019). Epigenetic changes during aging and their reprogramming potential. Crit. Rev. Biochem. Mol. Biol. 54 (1), 61–83. doi:10.1080/10409238.2019.1570075
Kleppa, L., Mari, P. O., Larsen, E., Lien, G. F., Godon, C., Theil, A. F., et al. (2012). Kinetics of endogenous mouse FEN1 in base excision repair. Nucleic Acids Res. 40 (18), 9044–9059. doi:10.1093/nar/gks673
Kong, S., Cai, B., and Nie, Q. (2022). PGC-1α affects skeletal muscle and adipose tissue development by regulating mitochondrial biogenesis. Mol. Genet. Genomics 297 (3), 621–633. doi:10.1007/s00438-022-01878-2
Kuipers, H. (1994). Exercise-induced muscle damage. Int. Journal Sports Medicine 15 (03), 132–135. doi:10.1055/s-2007-1021034
Kumari, R., and Jat, P. (2021). Mechanisms of cellular senescence: cell cycle arrest and senescence associated secretory phenotype. Front. Cell Developmental Biology 9, 645593. doi:10.3389/fcell.2021.645593
Lagunas-Rangel, F. A. (2023). DNA damage accumulation and repair defects in FLT3-ITD acute myeloid leukemia: implications for clonal evolution and disease progression. Hematol. Oncol. 41 (1), 26–38. doi:10.1002/hon.3076
Lee, G. K.-Y., Au, P. C.-M., Li, G. H.-Y., Chan, M., Li, H.-L., Cheung, B. M.-Y., et al. (2021). Sarcopenia and mortality in different clinical conditions: a meta-analysis. Osteoporos. Sarcopenia 7, S19–S27. doi:10.1016/j.afos.2021.02.001
Lee, S., Baek, S., Park, H., Han, K., Lee, K. P., and Ahn, S. H. (2024). A review of sarcopenia pathogenesis and therapeutic approaches: resistance exercise, nutrition, and monoterpenes. Phys. Activity Nutr. 28 (4), 83–91. doi:10.20463/pan.2024.0036
Li, G.-M. (2008). Mechanisms and functions of DNA mismatch repair. Cell Res. 18 (1), 85–98. doi:10.1038/cr.2007.115
Li, C., Liu, Q., Chang, Q., Xie, M., Weng, J., Wang, X., et al. (2023a). Role of mitochondrial fusion proteins MFN2 and OPA1 on lung cellular senescence in chronic obstructive pulmonary disease. Respir. Res. 24 (1), 319. doi:10.1186/s12931-023-02634-9
Li, Z., Anugula, S., and Rasmussen, L. J. (2023b). Genomic instability and aging. Aging: Elsevier, 275–295.
Liu, Y., Guo, C., Liu, S., Zhang, S., Mao, Y., and Fang, L. (2021). Eight weeks of high-intensity interval static strength training improves skeletal muscle atrophy and motor function in aged rats via the PGC-1α/FNDC5/UCP1 pathway. Clin. Interventions Aging 16, 811–821. doi:10.2147/CIA.S308893
Liu, N., Du, J., Ge, J., and Liu, S.-B. (2024). DNA damage-inducing endogenous and exogenous factors and research progress. Nucleosides, Nucleotides and Nucleic Acids 44, 1–33. doi:10.1080/15257770.2024.2428436
Lloyd, R. S. (2022). Complex roles of NEIL1 and OGG1: insights gained from murine knockouts and human polymorphic variants. Dna 2 (4), 279–301. doi:10.3390/dna2040020
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., and Kroemer, G. (2013). The hallmarks of aging. Cell 153 (6), 1194–1217. doi:10.1016/j.cell.2013.05.039
Lu, Y. R., Tian, X., and Sinclair, D. A. (2023). The information theory of aging. Nat. Aging 3 (12), 1486–1499. doi:10.1038/s43587-023-00527-6
Mano, Y., Tsukamoto, M., Wang, K.-Y., Nabeshima, T., Kosugi, K., Tajima, T., et al. (2022). Oxidative stress causes muscle structural alterations via p38 MAPK signaling in COPD mouse model. J. Bone Mineral Metabolism 40 (6), 927–939. doi:10.1007/s00774-022-01371-1
Mao, X., Meng, Q., Han, J., Shen, L., Sui, X., Gu, Y., et al. (2021a). Regulation of dynamin-related protein 1 (DRP1) levels modulates myoblast atrophy induced by C26 colon cancer-conditioned medium. Transl. Cancer Res. 10 (6), 3020–3032. doi:10.21037/tcr-21-751
Mao, X., Gu, Y., Sui, X., Shen, L., Han, J., Wang, H., et al. (2021b). Phosphorylation of dynamin-related protein 1 (DRP1) regulates mitochondrial dynamics and skeletal muscle wasting in cancer cachexia. Front. Cell Developmental Biology 9, 673618. doi:10.3389/fcell.2021.673618
Marqueze, L. F., Costa, A. K., Pedroso, G. S., Vasconcellos, F. F., Pilger, B. I., Kindermann, S., et al. (2023). Regulation of Redox profile and genomic instability by physical exercise contributes to neuroprotection in mice with experimental glioblastoma. Antioxidants 12 (7), 1343. doi:10.3390/antiox12071343
Maynard, S., Fang, E. F., Scheibye-Knudsen, M., Croteau, D. L., and Bohr, V. A. (2015). DNA damage, DNA repair, aging, and neurodegeneration. Cold Spring Harb. Perspectives Medicine 5 (10), a025130. doi:10.1101/cshperspect.a025130
Melov, S., Shoffner, J. M., Kaufman, A., and Wallace, D. (1995). Marked increase in the number and variety of mitochondrial DNA rearrangements in aging human skeletal muscle. Nucleic Acids Research 23 (20), 4122–4126. doi:10.1093/nar/23.20.4122
Miao, Y., Xie, L., Song, J., Cai, X., Yang, J., Ma, X., et al. (2024). Unraveling the causes of sarcopenia: roles of neuromuscular junction impairment and mitochondrial dysfunction. Physiol. Rep. 12 (1), e15917. doi:10.14814/phy2.15917
Monti, E., Sarto, F., Sartori, R., Zanchettin, G., Löfler, S., Kern, H., et al. (2023). C-terminal agrin fragment as a biomarker of muscle wasting and weakness: a narrative review. J. Cachexia, Sarcopenia Muscle 14 (2), 730–744. doi:10.1002/jcsm.13189
Moreno-Villanueva, M., Kramer, A., Hammes, T., Venegas-Carro, M., Thumm, P., Bürkle, A., et al. (2019). Influence of acute exercise on DNA repair and PARP activity before and after irradiation in lymphocytes from trained and untrained individuals. Int. J. Mol. Sci. 20 (12), 2999. doi:10.3390/ijms20122999
Morland, I., Rolseth, V., Luna, L., Rognes, T., Bjørås, M., and Seeberg, E. (2002). Human DNA glycosylases of the bacterial Fpg/MutM superfamily: an alternative pathway for the repair of 8-oxoguanine and other oxidation products in DNA. Nucleic Acids Res. 30 (22), 4926–4936. doi:10.1093/nar/gkf618
Nadalutti, C. A., Ayala-Peña, S., and Santos, J. H. (2022). Mitochondrial DNA damage as driver of cellular outcomes. Am. J. Physiology-Cell Physiology 322 (2), C136–C150. doi:10.1152/ajpcell.00389.2021
Naimo, M. A., Roberts, B. M., and Alway, S. E. (2024). Decoding muscle adaptation through skeletal muscle negative data: understanding the signaling factors involved. Frontiers Media SA.
Nelke, C., Dziewas, R., Minnerup, J., Meuth, S. G., and Ruck, T. (2019). Skeletal muscle as potential central link between sarcopenia and immune senescence. EBioMedicine 49, 381–388. doi:10.1016/j.ebiom.2019.10.034
Ohkawara, B., Ito, M., and Ohno, K. (2021). Secreted signaling molecules at the neuromuscular junction in physiology and pathology. Int. J. Mol. Sci. 22 (5), 2455. doi:10.3390/ijms22052455
Ohtani, N. (2022). The roles and mechanisms of senescence-associated secretory phenotype (SASP): can it be controlled by senolysis? Inflamm. Regeneration 42 (1), 11. doi:10.1186/s41232-022-00197-8
Paez, H. G., Pitzer, C. R., and Alway, S. E. (2023). Age-Related dysfunction in proteostasis and cellular quality control in the development of Sarcopenia. Cells 12 (2), 249. doi:10.3390/cells12020249
G. Panci, and B. Chazaud (2021). “Inflammation during post-injury skeletal muscle regeneration,” Seminars in Cell and Developmental Biology (Elsevier).
Peris-Moreno, D., Cussonneau, L., Combaret, L., Polge, C., and Taillandier, D. (2021). Ubiquitin ligases at the heart of skeletal muscle atrophy control. Molecules 26 (2), 407. doi:10.3390/molecules26020407
Pezone, A., Olivieri, F., Napoli, M. V., Procopio, A., Avvedimento, E. V., and Gabrielli, A. (2023). Inflammation and DNA damage: cause, effect or both. Nat. Rev. Rheumatol. 19 (4), 200–211. doi:10.1038/s41584-022-00905-1
Pinto, M., and Moraes, C. T. (2015). Mechanisms linking mtDNA damage and aging. Free Radic. Biol. Med. 85, 250–258. doi:10.1016/j.freeradbiomed.2015.05.005
Powers, S. K., Goldstein, E., Schrager, M., and Ji, L. L. (2022). Exercise training and skeletal muscle antioxidant enzymes: an update. Antioxidants 12 (1), 39. doi:10.3390/antiox12010039
Pratt, J., De Vito, G., Narici, M., Segurado, R., Pessanha, L., Dolan, J., et al. (2021). Plasma C-terminal agrin fragment as an early biomarker for sarcopenia: results from the GenoFit study. Journals Gerontology Ser. A 76 (12), 2090–2096. doi:10.1093/gerona/glab139
Purnamasari, D., Tetrasiwi, E. N., Kartiko, G. J., Astrella, C., Husam, K., and Laksmi, P. W. (2022). Sarcopenia and chronic complications of type 2 diabetes mellitus. Rev. Diabet. Stud. RDS 18 (3), 157–165. doi:10.1900/RDS.2022.18.157
Radák, Z., Apor, P., Pucsok, J., Berkes, I., Ogonovszky, H., Pavlik, G., et al. (2003). Marathon running alters the DNA base excision repair in human skeletal muscle. Life Sciences 72 (14), 1627–1633. doi:10.1016/s0024-3205(02)02476-1
Radak, Z., Atalay, M., Jakus, J., Boldogh, I., Davies, K., and Goto, S. (2009). Exercise improves import of 8-oxoguanine DNA glycosylase into the mitochondrial matrix of skeletal muscle and enhances the relative activity. Free Radic. Biol. Med. 46 (2), 238–243. doi:10.1016/j.freeradbiomed.2008.10.022
Rafiyan, M., Sadeghmousavi, S., Akbarzadehmoallemkolaei, M., and Rezaei, N. (2023). Experimental animal models of chronic inflammation. Curr. Res. Immunol. 4, 100063. doi:10.1016/j.crimmu.2023.100063
Rafiyan, M., Azadchehr, M. J., Fazeli, A. M., and Jalalati, N. (2025). Examining the prevalence of neck and hand disorders and its relationship with smartphone addiction in medical students. BMC Musculoskelet. Disord. 26 (1), 1–7. doi:10.1186/s12891-025-08809-3
Rafiyian, M., Reiter, R. J., Rasooli Manesh, S. M., Asemi, R., Sharifi, M., Mohammadi, S., et al. (2024). Programmed cell death and melatonin: a comprehensive review. Functional and integrative genomics. Funct. Integr. Genomics 24 (5), 169. doi:10.1007/s10142-024-01454-4
Rebelo-Marques, A., De Sousa Lages, A., Andrade, R., Ribeiro, C. F., Mota-Pinto, A., Carrilho, F., et al. (2018). Aging hallmarks: the benefits of physical exercise. Front. Endocrinology 9, 258. doi:10.3389/fendo.2018.00258
Reyes, G. X., Schmidt, T. T., Kolodner, R. D., and Hombauer, H. (2015). New insights into the mechanism of DNA mismatch repair. Chromosoma 124 (4), 443–462. doi:10.1007/s00412-015-0514-0
Riuzzi, F., Sorci, G., Arcuri, C., Giambanco, I., Bellezza, I., Minelli, A., et al. (2018). Cellular and molecular mechanisms of sarcopenia: the S100B perspective. J. Cachexia, Sarcopenia Muscle 9 (7), 1255–1268. doi:10.1002/jcsm.12363
Rogakou, E. P., Boon, C., Redon, C., and Bonner, W. M. (1999). Megabase chromatin domains involved in DNA double-strand breaks in vivo. J. Cell Biol. 146 (5), 905–916. doi:10.1083/jcb.146.5.905
Saad, E. E., Michel, R., and Borahay, M. A. (2024). Senescence-associated secretory phenotype (SASP) and uterine fibroids: association with PD-L1 activation and collagen deposition. Ageing Res. Rev. 97, 102314. doi:10.1016/j.arr.2024.102314
Schirrmacher, V. (2021). Less can be more: the hormesis theory of stress adaptation in the global biosphere and its implications. Biomedicines 9 (3), 293. doi:10.3390/biomedicines9030293
Schumacher, B., Pothof, J., Vijg, J., and Hoeijmakers, J. H. J. (2021). The central role of DNA damage in the ageing process. Nature 592 (7856), 695–703. doi:10.1038/s41586-021-03307-7
Sellami, M., Bragazzi, N., Prince, M. S., Denham, J., and Elrayess, M. (2021). Regular, intense exercise training as a healthy aging lifestyle strategy: preventing DNA damage, telomere shortening and adverse DNA methylation changes over a lifetime. Front. Genetics 12, 652497. doi:10.3389/fgene.2021.652497
S. Selvi, C. M. Real, M. Gentiluomo, K. Balounova, K. Vokacova, and A. Cumova (2025). “Genomic instability, DNA damage response and telomere homeostasis in pancreatic cancer,” Seminars in cancer biology (Elsevier).
Shadfar, S., Parakh, S., Jamali, M. S., and Atkin, J. D. (2023). Redox dysregulation as a driver for DNA damage and its relationship to neurodegenerative diseases. Transl. Neurodegeneration 12 (1), 18. doi:10.1186/s40035-023-00350-4
Shamsnia, E., Matinhomaee, H., Azarbayjani, M. A., and Peeri, M. (2023). The effect of aerobic exercise on oxidative stress in skeletal muscle tissue: a narrative review. Gene Cell Tissue 10. doi:10.5812/gct-131964
Shi, W., Tan, C., Liu, C., and Chen, D. (2023). Mitochondrial fission mediated by Drp1-Fis1 pathway and neurodegenerative diseases. Rev. Neurosci. 34 (3), 275–294. doi:10.1515/revneuro-2022-0056
Shmulevich, R., and Krizhanovsky, V. (2021). Cell senescence, DNA damage, and metabolism. Antioxidants and Redox Signaling 34 (4), 324–334. doi:10.1089/ars.2020.8043
Shuck, S. C., Short, E. A., and Turchi, J. J. (2008). Eukaryotic nucleotide excision repair: from understanding mechanisms to influencing biology. Cell Res. 18 (1), 64–72. doi:10.1038/cr.2008.2
Sirago, G., Picca, A., Calvani, R., Coelho-Júnior, H. J., and Marzetti, E. (2022). Mammalian target of rapamycin (mTOR) signaling at the crossroad of muscle fiber fate in sarcopenia. Int. J. Mol. Sci. 23 (22), 13823. doi:10.3390/ijms232213823
Soares, J. P., Silva, A. M., Oliveira, M. M., Peixoto, F., Gaivão, I., and Mota, M. P. (2015). Effects of combined physical exercise training on DNA damage and repair capacity: role of oxidative stress changes. Age (Dordr). 37 (3), 9799. doi:10.1007/s11357-015-9799-4
Sorriento, D., Di Vaia, E., and Iaccarino, G. (2021). Physical exercise: a novel tool to protect mitochondrial health. Front. Physiology 12, 660068. doi:10.3389/fphys.2021.660068
Sousa-Victor, P., Perdiguero, E., and Muñoz-Cánoves, P. (2014). Geroconversion of aged muscle stem cells under regenerative pressure. Cell Cycle 13 (20), 3183–3190. doi:10.4161/15384101.2014.965072
Sousa-Victor, P., García-Prat, L., and Muñoz-Cánoves, P. (2022). Control of satellite cell function in muscle regeneration and its disruption in ageing. Nat. Rev. Mol. Cell Biol. 23 (3), 204–226. doi:10.1038/s41580-021-00421-2
Sun, S., Shen, Y., Zhang, X., Ding, N., Xu, Z., Zhang, Q., et al. (2024). The MuSK agonist antibody protects the neuromuscular junction and extends the lifespan in C9orf72-ALS mice. Mol. Ther. 32 (7), 2176–2189. doi:10.1016/j.ymthe.2024.05.016
Thirupathi, A., Wang, M., Lin, J. K., Fekete, G., István, B., Baker, J. S., et al. (2021). Effect of different exercise modalities on oxidative stress: a systematic review. BioMed Res. Int. 2021 (1), 1947928. doi:10.1155/2021/1947928
Tryfidou, D. V., McClean, C., Nikolaidis, M. G., and Davison, G. W. (2020). DNA damage following acute aerobic exercise: a systematic review and meta-analysis. Sports Medicine 50, 103–127. doi:10.1007/s40279-019-01181-y
Veschetti, L., Treccani, M., De Tomi, E., and Malerba, G. (2023). Genomic instability evolutionary footprints on human health: driving forces or side effects? Int. J. Mol. Sci. 24 (14), 11437. doi:10.3390/ijms241411437
Walczak, K., Stawski, R., Perdas, E., Brzezinska, O., Kosielski, P., Galczynski, S., et al. (2021). Circulating cell free DNA response to exhaustive exercise in average trained men with type I diabetes mellitus. Sci. Rep. 11 (1), 4639. doi:10.1038/s41598-021-84201-0
Wang, T. (2022). Searching for the link between inflammaging and sarcopenia. Ageing Res. Rev. 77, 101611. doi:10.1016/j.arr.2022.101611
Wang, X., Pickrell, A. M., Rossi, S. G., Pinto, M., Dillon, L. M., Hida, A., et al. (2013). Transient systemic mtDNA damage leads to muscle wasting by reducing the satellite cell pool. Hum. Mol. Genet. 22 (19), 3976–3986. doi:10.1093/hmg/ddt251
Wang, H., Yang, R., Xu, J., Fang, K., Abdelrahim, M., and Chang, L. (2021a). Sarcopenia as a predictor of postoperative risk of complications, mortality and length of stay following gastrointestinal oncological surgery. Ann. R. Coll. Surg. Engl. 103 (9), 630–637. doi:10.1308/rcsann.2021.0082
Wang, F., Wang, X., Liu, Y., and Zhang, Z. (2021b). Effects of exercise-induced ROS on the pathophysiological functions of skeletal muscle. Oxidative Medicine Cellular Longevity 2021 (1), 3846122. doi:10.1155/2021/3846122
Wang, K., Gan, M., Lei, Y., Liao, T., Li, J., Niu, L., et al. (2025). Perspectives on mitochondrial dysfunction in the regeneration of aging skeletal muscle. Cell Mol. Biol. Lett. 30 (1), 94. doi:10.1186/s11658-025-00771-1
Welch, G., and Tsai, L. H. (2022). Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease. EMBO Reports 23 (6), e54217. doi:10.15252/embr.202154217
Widmann, M., Nieß, A. M., and Munz, B. (2019). Physical exercise and epigenetic modifications in skeletal muscle. Sports Medicine 49 (4), 509–523. doi:10.1007/s40279-019-01070-4
A. F. Widodo, C.-W. Tien, C.-W. Chen, and S.-C. Lai (2022). “Isotonic and isometric exercise interventions improve the hamstring muscles’ strength and flexibility: a narrative review,” (MDPI).
Wiedmer, P., Jung, T., Castro, J. P., Pomatto, L. C. D., Sun, P. Y., Davies, K. J. A., et al. (2021). Sarcopenia – molecular mechanisms and open questions. Ageing Res. Rev. 65, 101200. doi:10.1016/j.arr.2020.101200
Wu, W., Wang, J., Xiao, C., Su, Z., Su, H., Zhong, W., et al. (2021). SMYD2-mediated TRAF2 methylation promotes the NF-κB signaling pathways in inflammatory diseases. Clin. Transl. Med. 11 (11), e591. doi:10.1002/ctm2.591
Wu, S.-E., Hsu, J.-C., Chang, Y.-L., Chuang, H.-C., Chiu, Y.-L., and Chen, W.-L. (2022). Benzo [a] pyrene exposure in muscle triggers sarcopenia through aryl hydrocarbon receptor-mediated reactive oxygen species production. Ecotoxicol. Environ. Saf. 239, 113599. doi:10.1016/j.ecoenv.2022.113599
M. Xiao, X. Xu, and J. Lu (2021). “Effect of high-intensity interval training and accumulated exercise on PGC-1α and SIRT3 levels in the skeletal muscle of rats and bioinformatics analysis,” 2021 international conference on information technology and contemporary sports (TCS) (IEEE).
Xu, X., and Wen, Z. (2023). The mediating role of inflammaging between mitochondrial dysfunction and sarcopenia in aging: a review. Am. Journal Clinical Experimental Immunology 12 (6), 109–126.
Xu, J., Wan, C. S., Ktoris, K., Reijnierse, E. M., and Maier, A. B. (2022). Sarcopenia is associated with mortality in adults: a systematic review and meta-analysis. Gerontology 68 (4), 361–376. doi:10.1159/000517099
Yang, K., Hou, R., Zhao, J., Wang, X., Wei, J., Pan, X., et al. (2023). Lifestyle effects on aging and CVD: a spotlight on the nutrient-sensing network. Ageing Res. Rev. 92, 102121. doi:10.1016/j.arr.2023.102121
Ye, M., Dewi, L., Liao, Y.-C., Nicholls, A., Huang, C.-Y., and Kuo, C.-H. (2023). DNA oxidation after exercise: a systematic review and meta-analysis. Front. Physiology 14, 1275867. doi:10.3389/fphys.2023.1275867
Yousefzadeh, M., Henpita, C., Vyas, R., Soto-Palma, C., Robbins, P., and Niedernhofer, L. (2021). DNA damage—how and why we age? Elife 10, e62852. doi:10.7554/eLife.62852
Zanini, G., De Gaetano, A., Selleri, V., Savino, G., Cossarizza, A., Pinti, M., et al. (2021). Mitochondrial DNA and exercise: implications for health and injuries in sports. Cells 10 (10), 2575. doi:10.3390/cells10102575
Zhang, X., Yin, M., and Hu, J. (2022). Nucleotide excision repair: a versatile and smart toolkit. Acta Biochim. Biophys. Sin. (Shanghai) 54 (6), 807–819. doi:10.3724/abbs.2022054
Zhao, Y., Simon, M., Seluanov, A., and Gorbunova, V. (2023a). DNA damage and repair in age-related inflammation. Nat. Rev. Immunol. 23 (2), 75–89. doi:10.1038/s41577-022-00751-y
Zhao, Y., Ye, X., Xiong, Z., Ihsan, A., Ares, I., Martínez, M., et al. (2023b). Cancer metabolism: the role of ROS in DNA damage and induction of apoptosis in cancer cells. Metabolites 13 (7), 796. doi:10.3390/metabo13070796
Zheng, P., Ma, W., Gu, Y., Wu, H., Bian, Z., Liu, N., et al. (2023). High-fat diet causes mitochondrial damage and downregulation of mitofusin-2 and optic atrophy-1 in multiple organs. J. Clin. Biochem. Nutr. 73 (1), 61–76. doi:10.3164/jcbn.22-73
Zhong, Y., Zhang, X., Feng, R., Fan, Y., Zhang, Z., Zhang, Q. W., et al. (2024). OGG1: an emerging multifunctional therapeutic target for the treatment of diseases caused by oxidative DNA damage. Med. Res. Rev. 44 (6), 2825–2848. doi:10.1002/med.22068
Zhu, Y., Zhou, X., Zhu, A., Xiong, S., Xie, J., and Bai, Z. (2023). Advances in exercise to alleviate sarcopenia in older adults by improving mitochondrial dysfunction. Front. Physiol. 14, 1196426. doi:10.3389/fphys.2023.1196426
Keywords: aging, DNA damage repair, exercise, physical activtiy, sarcopenia
Citation: Zhu L, Su Y and Su Z (2026) Impact of exercise-induced DNA damage repair on age-related muscle weakness and sarcopenia. Front. Genet. 16:1639224. doi: 10.3389/fgene.2025.1639224
Received: 01 June 2025; Accepted: 11 December 2025;
Published: 07 January 2026.
Edited by:
Marios Spanakis, University of Crete, GreeceReviewed by:
Stefano Donegà, National Institute on Aging (NIH), United StatesCéline Baldeyron, Institut de Radioprotection et de Sûreté Nucléaire, France
Copyright © 2026 Zhu, Su and Su. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Zhanguo Su, c2h1anVhbnlhbmc1ODJAZ21haWwuY29t; Lingyan Zhu, MTgzNjU0MDg4MzlAMTYzLmNvbQ==